Skip to content

Clinical trials

Phase 3 Kidney Failure, Chronic trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Failure, Chronic Phase: Phase 3 Country / region: Germany Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20073
20081
20092
20101
20121
20142
20151
20161
20172
20181
20201
20223
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated3
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Affymax2
Cara Therapeutics, Inc.2
Amgen1
Astellas Pharma Europe B.V.1
Astellas Pharma Global Development, Inc.1
Atrial Fibrillation Network1
Bristol-Myers Squibb1
Dynavax Technologies Corporation1
Eli Lilly and Company1
Fresenius Medical Care Deutschland GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Failure, Chronic23
Renal Insufficiency, Chronic12
Anemia5
Kidney Diseases3
Cardiovascular Diseases2
Diabetes Mellitus, Type 22
Hypertension2
Pruritus2
Renal Insufficiency2
Atherosclerosis1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.